Filing Details

Accession Number:
0001127602-13-010986
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-03-15 17:03:18
Reporting Period:
2013-03-15
Filing Date:
2013-03-15
Accepted Time:
2013-03-15 17:03:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1520262 Alkermes Plc. ALKS Pharmaceutical Preparations (2834) 981007018
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1376545 G Gordon Pugh 852 Winter St.
Waltham MA 02451
Svp, Coo & Cro, Alkermes, Inc. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2013-03-15 4,502 $23.09 9,833 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Ordinary Shares 5,000 Indirect Gordon G. Pugh Revocable Trust - 2012
Ordinary Shares 15,000 Indirect Nancy E. Pugh Revocable Trust - 2012
Footnotes
  1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.03 to $23.16. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.